InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
80.65
(
1.13%
)
Bitcoin
68,042.69
(
0.35%
)
Post# of 58465
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Sprycel

Send PM Follow Ignore
Followers 423
Posts 39062
Boards Moderated 2
Alias Born 12/21/2006

Sprycel

Re: Traderworld post# 9071

Wednesday, 02/18/2009 1:28:29 PM

Wednesday, February 18, 2009 1:28:29 PM

Post# of 58465
The CEO stated in the conference call that he was currently in negotiations for partnership agreements for all three drugs! I suspect we would first hear of a partnership for Tesetaxel to fund Phase 3 clinical trials due to the company being given Orphan Status for Tesetaxel. That would provide exclusivity for the manufacture and marketing for Tesetaxel for 3 years! As far as Genasense is concerned I believe we will find out within 30 days what role this drug will play for GENTA and who the partner will be!! GENTA is not large enough to market this product worldwide so a major Pharma is needed!!
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up